These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9434158)

  • 1. DNA topoisomerase II cleavage of telomeres in vitro and in vivo.
    Yoon HJ; Choi IY; Kang MR; Kim SS; Muller MT; Spitzner JR; Chung IK
    Biochim Biophys Acta; 1998 Jan; 1395(1):110-20. PubMed ID: 9434158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomeric DNA damage by topoisomerase I. A possible mechanism for cell killing by camptothecin.
    Kang MR; Muller MT; Chung IK
    J Biol Chem; 2004 Mar; 279(13):12535-41. PubMed ID: 14729676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage.
    Lee CC; Huang TS
    Pharm Res; 2001 Jun; 18(6):846-51. PubMed ID: 11474790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon.
    Nahon E; Best-Belpomme M; Saucier JM
    Eur J Biochem; 1993 Nov; 218(1):95-102. PubMed ID: 8243480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
    Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
    Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.
    Bandele OJ; Osheroff N
    Biochemistry; 2008 Nov; 47(45):11900-8. PubMed ID: 18922022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.
    Kingma PS; Greider CA; Osheroff N
    Biochemistry; 1997 May; 36(20):5934-9. PubMed ID: 9166762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats.
    Spitzner JR; Chung IK; Muller MT
    Nucleic Acids Res; 1990 Jan; 18(1):1-11. PubMed ID: 2155393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
    Ritke MK; Allan WP; Fattman C; Gunduz NN; Yalowich JC
    Mol Pharmacol; 1994 Jul; 46(1):58-66. PubMed ID: 8058057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
    Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.
    Infante Lara L; Fenner S; Ratcliffe S; Isidro-Llobet A; Hann M; Bax B; Osheroff N
    Nucleic Acids Res; 2018 Mar; 46(5):2218-2233. PubMed ID: 29447373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML; Hsu MT
    J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
    Wilstermann AM; Osheroff N
    Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum.
    Weissig V; Vetro-Widenhouse TS; Rowe TC
    DNA Cell Biol; 1997 Dec; 16(12):1483-92. PubMed ID: 9428797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apurinic sites are position-specific topoisomerase II poisons.
    Kingma PS; Osheroff N
    J Biol Chem; 1997 Jan; 272(2):1148-55. PubMed ID: 8995415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons.
    Borgnetto ME; Tinelli S; Carminati L; Capranico G
    J Mol Biol; 1999 Jan; 285(2):545-54. PubMed ID: 9878428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
    Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
    Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence on the chromosomal location of centromeric DNA in Plasmodium falciparum from etoposide-mediated topoisomerase-II cleavage.
    Kelly JM; McRobert L; Baker DA
    Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6706-11. PubMed ID: 16617116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of telomeres in Etoposide induced tumor cell death.
    Jeyapalan J; Leake A; Ahmed S; Saretzki G; Tilby M; von Zglinicki T
    Cell Cycle; 2004 Sep; 3(9):1169-76. PubMed ID: 15326395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.